1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CORVUS PHARMACEUTICALS INC
Corvus Pharmaceuticals Inc XNAS: CRVS

Corvus Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

about

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind s...

Read More
4.38 -0.14 (-3.10%)
56.20% Fall from 52W High
403.0K
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Corvus Pharmaceuticals Inc is on 06 Aug 2025 for the purpose of Corvus Pharmaceuticals Inc Second Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
3.5 / 100
Momentum Score
Technically Neutral
52.4 / 100
Analyst Price Target
No estimates available

11

S

9

W

2

O

1

T

SWOT Analysis

Corvus Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..